Bibliographic Details
| Title: |
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial). |
| Authors: |
Correale P; Section of Medical Oncology, Department 'Giorgio Segre' of Pharmacology, Rheumatology Unit, Siena University School of Medicine, Siena, Italy., Tagliaferri P, Fioravanti A, Del Vecchio MT, Remondo C, Montagnani F, Rotundo MS, Ginanneschi C, Martellucci I, Francini E, Cusi MG, Tassone P, Francini G |
| Source: |
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2008 Jul 01; Vol. 14 (13), pp. 4192-9. |
| Publication Type: |
Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
